The patent EP4552698A3 was granted to Janssen Pharmaceutica on Jul 30, 2025 following the initial filing on Jul 28, 2017 under the application number EP25153097A . The current legal status of the patent is Published.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents